康惠制药 (603139.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(康惠制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 138,877,194.20138,301,269.49127,367,068.27200,731,975.42202,931,449.18145,504,766.58123,792,050.57
 营业收入(元) 138,877,194.20138,301,269.49127,367,068.27200,731,975.42202,931,449.18145,504,766.58123,792,050.57
二、营业总成本(元) 166,685,791.30155,391,036.65133,377,175.40214,673,858.61209,273,210.49142,496,773.13118,797,207.65
 营业成本(元) 95,736,448.3192,771,913.3885,992,349.81150,442,040.63154,183,788.9198,142,835.4280,979,718.31
 研发费用(元) 1,310,740.521,562,021.271,824,618.483,496,728.493,205,173.162,295,761.161,982,426.70
 营业税金及附加(元) 2,502,970.643,253,253.553,505,313.331,997,489.171,373,179.671,070,315.13863,797.58
 销售费用(元) 45,119,651.8239,680,688.7120,621,173.4334,846,733.5430,382,053.2929,783,322.4926,671,890.42
 管理费用(元) 14,133,549.1110,633,408.1214,286,017.4115,095,917.8411,379,297.8211,030,602.517,724,781.46
 财务费用(元) 7,882,430.907,489,751.627,147,702.948,794,948.938,749,717.64173,936.43574,593.18
  其中:利息费用(元) 9,312,207.258,245,249.567,820,156.669,140,356.9710,195,980.021,700,823.812,423,942.02
  其中:利息收入(元) 947,187.88737,293.73781,968.27195,038.061,673,540.651,717,528.061,738,358.61
 资产减值损失(元) -767,591.2337,983.83-37,055.92-23,114,638.68218,250.032,297,905.21-146,092.87
 信用减值损失(元) -819,844.52-4,636,658.001,560,111.06-576,616.23-5,565,910.94-1,468,635.063,783,094.40
三、其他经营收益
 加:公允价值变动收益(元) 800,000.00---341.03-72,058.50--
 加:投资收益(元) -9,202,949.9910,930,402.60576,639.86-29,678,958.162,304,895.03-1,274,915.205,112.67
  其中:对联营企业和合营企业的投资收益(元) ----27,063,505.39---
 资产处置收益(元) --30,628.48-3,653.8322,977.53---
 其他收益(元) 1,168,919.031,402,119.262,689,010.392,680,314.89539,079.29266,432.53214,804.98
 营业利润平衡项目(元) --0.01----
四、营业利润(元) -36,630,063.81-8,124,629.96-1,225,055.56-64,609,144.87-8,917,506.402,872,332.678,851,762.10
 加:营业外收入(元) 295,605.1372,114.4073,455.144,798,000.1016,268.35-70,144.3395,528.01
 减:营业外支出(元) 37,926.78240,587.81437,091.27852,479.6612,814.92114,554.00558.31
五、利润总额(元) -36,372,385.46-8,293,103.37-1,588,691.69-60,663,624.43-8,914,052.972,687,634.348,946,731.80
 减:所得税费用(元) -5,698,565.836,332,300.25894,298.91-8,782,488.30-1,092,064.652,041,045.42665,392.64
六、净利润(元) -30,673,819.63-14,625,403.62-2,482,990.60-51,881,136.13-7,821,988.31646,588.918,281,339.16
(一)按经营持续性分类
  持续经营净利润(元) -30,673,819.63-14,625,403.62-2,482,990.60-51,881,136.13-7,821,988.31646,588.918,281,339.16
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -29,586,464.94-9,788,271.541,086,299.01-35,380,286.37-3,377,492.684,392,807.568,206,330.75
  少数股东损益(元) -1,087,354.69-4,837,132.08-3,569,289.61-16,500,849.76-4,444,495.63-3,746,218.6575,008.41
 扣除非经常性损益后的净利润(元) -28,481,860.10-15,867,536.11-119,103.68-38,213,916.23-6,729,675.764,269,090.858,016,925.33
七、每股收益
 一、基本每股收益(元) -0.29-0.100.01-0.35-0.040.050.08
 二、稀释每股收益(元) -0.29-0.100.01-0.35-0.040.050.08
九、综合收益总额(元) -30,673,819.63-14,625,403.62-2,482,990.60-49,990,161.72-7,821,988.31646,588.918,281,339.16
 归属于母公司所有者的综合收益总额(元) -29,586,464.94-9,788,271.541,086,299.01-33,489,311.96-3,377,492.684,392,807.568,206,330.75
 归属于少数股东的综合收益总额(元) -1,087,354.69-4,837,132.08-3,569,289.61-16,500,849.76-4,444,495.63-3,746,218.6575,008.41
公告日期 2024-10-312024-08-302024-04-272024-04-272023-10-282023-08-312023-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院